DCOY - Salarius Pharmaceuticals, Inc.
0.6318
0.049 7.803%
Share volume: 166,135
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.26%
PREVIOUS CLOSE
CHG
CHG%
$0.58
0.05
0.08%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-13-2024 | 08-09-2024 | 11-14-2024 | 03-21-2025 | 05-14-2025 | 08-12-2025 | 11-14-2025 | |
| Assets | ||||||||
| Total Assets | 4.884 M | 3.554 M | 3.859 M | 3.023 M | 2.339 M | 1.393 M | 6.097 M | |
| Current Assets | 4.830 M | 3.514 M | 3.823 M | 2.988 M | 2.305 M | 1.360 M | 6.065 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 4.373 M | 3.273 M | 3.284 M | 2.435 M | 1.798 M | 794.886 K | 4.810 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Assets | 53.390 K | 39.931 K | 36.518 K | 35.412 K | 34.306 K | 33.200 K | 32.094 K | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 4.884 M | 3.554 M | 3.859 M | 3.023 M | 2.339 M | 1.393 M | 6.097 M | |
| Total liabilities | 1.234 M | 1.178 M | 934.581 K | 1.511 M | 2.278 M | 2.223 M | 1.849 M | |
| Total current liabilities | 1.234 M | 1.178 M | 934.581 K | 1.511 M | 2.278 M | 2.223 M | 1.849 M | |
| Accounts Payable | 713.957 K | 643.051 K | 165.801 K | 936.994 K | 1.471 M | 1.482 M | 1.104 M | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 3.650 M | 2.375 M | 2.925 M | 1.512 M | 61.866 K | -829.724 K | 4.248 M | |
| Common stock | 81.713 M | 81.863 M | 83.384 M | 83.435 M | 83.695 M | 83.761 M | 89.713 M | |
| Retained earnings | -78.063 M | -79.488 M | -80.460 M | -81.924 M | -83.633 M | -84.591 M | -85.464 M |